Meeting Coverage
>
ASN
—
Surrogate endpoint of urinary protein-to-creatinine ratio “widely considered to be predictive”
by
Kristen Monaco, Senior Staff Writer, MedPage Today
October 27, 2024
SAN DIEGO — A novel drug significantly reduced IgA nephropathy-related proteinuria, according to interim findings of the ALIGN study.
In the phase III trial, among 270 patients with the rare kidney disorder, those on atrasentan had a 36.1 percentage point (95% CI -44.6 to -26.4, P
Information contained on this page is provided by an independent third-party content provider. This website makes no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact editor @americanfork.business
